DENTSPLY SIRONA (NASDAQ:XRAY) Announces Earnings Results

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) announced its quarterly earnings results on Monday. The medical instruments supplier reported $0.41 earnings per share for the quarter, missing analysts’ consensus estimates of $0.59 by ($0.18), Briefing.com reports. DENTSPLY SIRONA had a net margin of 8.81% and a return on equity of 11.63%. The company had revenue of $947.00 million during the quarter, compared to the consensus estimate of $1.01 billion. During the same period in the previous year, the firm posted $0.68 EPS. The business’s quarterly revenue was down 8.9% compared to the same quarter last year. DENTSPLY SIRONA updated its FY 2022 guidance to $1.90-$2.00 EPS and its FY22 guidance to $1.90-2.00 EPS.

DENTSPLY SIRONA Stock Down 3.5 %

XRAY traded down $1.12 during trading on Monday, reaching $30.93. 94,246 shares of the stock were exchanged, compared to its average volume of 2,242,948. The stock has a market cap of $6.65 billion, a P/E ratio of 18.96, a price-to-earnings-growth ratio of 3.46 and a beta of 0.95. DENTSPLY SIRONA has a twelve month low of $26.48 and a twelve month high of $58.70. The stock’s 50 day moving average price is $30.06 and its two-hundred day moving average price is $34.44. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 1.45.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of institutional investors have recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust increased its holdings in shares of DENTSPLY SIRONA by 163.7% in the first quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after purchasing an additional 568 shares during the last quarter. Covestor Ltd lifted its position in DENTSPLY SIRONA by 97.8% during the first quarter. Covestor Ltd now owns 3,198 shares of the medical instruments supplier’s stock worth $157,000 after purchasing an additional 1,581 shares during the period. KB Financial Partners LLC lifted its holdings in shares of DENTSPLY SIRONA by 19.5% in the first quarter. KB Financial Partners LLC now owns 4,443 shares of the medical instruments supplier’s stock worth $219,000 after acquiring an additional 726 shares during the last quarter. Captrust Financial Advisors lifted its holdings in shares of DENTSPLY SIRONA by 14.0% in the first quarter. Captrust Financial Advisors now owns 4,446 shares of the medical instruments supplier’s stock worth $219,000 after acquiring an additional 546 shares during the last quarter. Finally, Prudential PLC bought a new position in shares of DENTSPLY SIRONA in the first quarter worth about $231,000. 96.00% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

XRAY has been the topic of a number of research reports. William Blair reaffirmed an “underperform” rating on shares of DENTSPLY SIRONA in a research note on Tuesday, November 1st. The Goldman Sachs Group lowered their price objective on shares of DENTSPLY SIRONA from $42.00 to $41.00 and set a “neutral” rating on the stock in a report on Thursday, July 21st. StockNews.com began coverage on shares of DENTSPLY SIRONA in a report on Wednesday, October 12th. They issued a “hold” rating on the stock. Finally, Morgan Stanley lowered their price objective on shares of DENTSPLY SIRONA from $44.00 to $42.00 and set an “overweight” rating on the stock in a report on Thursday, October 13th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $47.89.

DENTSPLY SIRONA Company Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Featured Articles

Earnings History for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.